Internal Medicine, Hematology & Oncology · Goldsboro, NC
NPI
1881702595
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
203 Cox Blvd
Goldsboro, NC, 27534
Phone (919) 580-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
251,967 services
Medicare patients, 2024
1,117
Average age 75
Drug cost, 2024
$8.1M
3,038 prescriptions
Company payments, 2025
$1,959
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samer S Kasbari was code J1439 (injection, ferric carboxymaltose, 1 mg), 48,000 times for 53 patients. In total Samer S Kasbari billed 251,967 services in 149 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 48,000 | 53 | $0.87 | $42K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 31,110 | 51 | $0.29 | $8,981 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 20,000 | 28 | $2.32 | $46K |
| J0897 Injection, denosumab, 1 mg | Office | 15,974 | 159 | $20.18 | $322K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 12,800 | 14 | $0.06 | $710 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,658 | 69 | $0.09 | $238 |
| 85025 Blood Count | Office | 2,328 | 755 | $7.52 | $18K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,100 | 20 | $14.57 | $31K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 1,640 | 14 | $0.07 | $115 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,500 | 47 | $0.71 | $1,065 |
| 36415 Venipuncture Blood Collection | Office | 1,408 | 744 | $7.80 | $11K |
| 80053 Clinical Chemistry | Office | 1,245 | 606 | $10.23 | $13K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,100 | 19 | $3.51 | $3,857 |
| 96372 Injection Administration | Office | 947 | 354 | $10.79 | $10K |
| 99214 Office E&M - Established | Office | 903 | 459 | $94.52 | $85K |
By year: 2022 $2.9M for 240,928 services; 2023 $3.0M for 178,279 services; 2024 $2.9M for 251,967 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,328 | 755 | $7.52 | $18K |
| 36415 Venipuncture Blood Collection | 1,408 | 744 | $7.80 | $11K |
| 80053 Clinical Chemistry | 1,245 | 606 | $10.23 | $13K |
| 82728 Clinical Chemistry | 410 | 255 | $13.29 | $5,451 |
| 83735 Clinical Chemistry | 182 | 74 | $6.57 | $1,196 |
| 83540 Clinical Chemistry | 180 | 149 | $6.27 | $1,129 |
| 83550 Clinical Chemistry | 180 | 149 | $8.47 | $1,525 |
| 81001 Clinical Chemistry | 113 | 48 | $3.06 | $346 |
| 85610 Clinical Chemistry | 83 | 13 | $4.20 | $349 |
Medicare prescription drug claims, 2024
In 2024, the drug Samer S Kasbari prescribed most often to Medicare patients was Anastrozole, with 233 prescriptions and refills. In total Samer S Kasbari wrote 3,038 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 233 | 487 | 51 | $3,662 |
| Tamoxifen Citrate Generic | 173 | 278 | 36 | $3,397 |
| Ondansetron Hcl Generic | 127 | 133 | 72 | $1,739 |
| Prolia Denosumab | 112 | 671 | 70 | $189K |
| Gabapentin Generic | 103 | 111 | 34 | $1,081 |
| Revlimid Lenalidomide | 99 | 99 | 14 | $1.7M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 82 | 82 | 22 | $2,119 |
| Eliquis Apixaban | 81 | 85 | 20 | $47K |
| Dexamethasone Generic | 71 | 85 | 30 | $1,156 |
| Prednisone Generic | 69 | 70 | 25 | $314 |
| Warfarin Sodium Generic | 69 | 111 | Under 11 | $243 |
| Exemestane Generic | 68 | 82 | 18 | $5,489 |
| Megestrol Acetate Generic | 67 | 73 | 30 | $3,471 |
| Promethazine Hcl Generic | 61 | 61 | 45 | $546 |
| Levothyroxine Sodium Generic | 61 | 67 | Under 11 | $315 |
Brand drugs: 809 claims; generic drugs: 2,229 claims; opioid claims: 322.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samer S Kasbari $1,959 ($1,959 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,035.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $1,035 |
| Eisai Inc. 4523.T | 5 | $116 |
| Janssen Biotech, Inc. JNJ | 4 | $100 |
| Pfizer Inc. PFE | 3 | $75.78 |
| Celgene Corporation BMY | 3 | $58.5 |
| GlaxoSmithKline, LLC. GSK | 3 | $54.73 |
| Genentech USA, Inc. ROG.SW | 1 | $53.45 |
| Taiho Oncology, Inc. 4578.T | 1 | $49.4 |
| Abbvie Inc. ABBV | 2 | $45.01 |
| Stemline Therapeutics Inc. | 1 | $31.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.